Clinical sample analysis further validated the important role of BHLHE40 in the prognosis and progression of PDAC, and BHLHE40 was positively correlated with lymph node metastasis, T stage, and AJCC stage and negatively correlated with survival time. This evidence concerns the gene BHLHE40 and metastatic malignant neoplasm in the lymph nodes.